Low HDL cholesterol is associated with increased atherogenic lipoproteins and insulin resistance in women classified with metabolic syndrome

다국어 초록 (Multilingual Abstract)

Both metabolic syndrome (MetS) and elevated LDL cholesterol (LDL-C) increase the risk for cardiovascular disease (CVD). We hypothesized that low HDL cholesterol (HDL-C) would further increase CVD risk in women having both conditions. To assess this, we recruited 89 women with MetS (25-72 y) and LDL-C ≥ 2.6 mmol/L. To determine whether plasma HDL-C concentrations were associated with dietary components, circulating atherogenic particles, and other risk factors for CVD, we divided the subjects into two groups: high HDL-C (H-HDL) (≥ 1.3 mmol/L, n = 32) and low HDL-C (L-HDL) (＜ 1.3 mmol/L, n = 57). Plasma lipids, insulin, adiponectin, apolipoproteins, oxidized LDL, Lipoprotein(a), and lipoprotein size and subfractions were measured, and 3-d dietary records were used to assess macronutrient intake. Women with L-HDL had higher sugar intake and glycemic load (P ＜ 0.05), higher plasma insulin (P < 0.01), lower adiponectin (P ＜ 0.05), and higher numbers of atherogenic lipoproteins such as large VLDL (P ＜ 0.01) and small LDL (P < 0.001) than the H-HDL group. Women with L-HDL also had larger VLDL and both smaller LDL and HDL particle diameters (P ＜ 0.001). HDL-C was positively correlated with LDL size (r = 0.691, P ＜ 0.0001) and HDL size (r = 0.606, P ＜ 0.001), and inversely correlated with VLDL size (r = -0.327, P ＜ 0.01). We concluded that L-HDL could be used as a marker for increased numbers of circulating atherogenic lipoproteins as well as increased insulin resistance in women who are already at risk for CVD.

목차 (Table of Contents)

• Abstract
• Introduction
• Subjects and Methods
• Results
• Discussion
• References

참고문헌 (Reference)

1 Marotta T, "Triglyceride-to-HDL cholesterol ratio and metabolic syndrome as contributors to cardiovascular risk in overweight patients" 18 : 1608-1613, 2010

2 Haffner SM, "The homeostasis model in the San Antonio Heart Study" 120 : 1087-1092, 1997

3 Murphy AJ, "The anti inflammatory effects of high density lipoproteins" 16 : 667-675, 2009

4 Fernandez ML, "The Metabolic Syndrome" 65 : S30-S34, 2007

5 Saddar S, "Signaling by the high-affinity HDL receptor scavenger receptor B type I" 30 : 144-150, 2010

6 Zambon A, "Relevance of hepatic lipase to the metabolism of triacylglycerol-rich lipoproteins" 31 : 1070-1074, 2003

7 Krauss RM, "Relationship of intermediate and low-density lipoprotein subspecies to risk of coronary heart disease" 113 : 578-582, 1987

8 Cnop M, "Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex" 46 : 459-469, 2003

9 Zhang B, "Predicted coronary risk for adults with coronary heart disease and low HDL-C: an analysis from the US National Health and Nutrition Examination Survey" 24 : 2711-2717, 2008

10 Hotta K, "Plasma concentrations of a novel, adiposespecific protein, adiponectin, in type 2 diabetic patients" 20 : 1595-1599, 2000

11 Rosenblat M, "Paraoxonases role in the prevention of cardiovascular diseases" 35 : 98-104, 2009

12 Liu MY, "Multiplexed analysis of biomarkers related to obesity and the metabolic syndrome in human plasma, using the Luminex-100 system" 51 : 1102-1109, 2005

13 Itabe H, "Minimally modified LDL is an oxidized LDL enriched with oxidized phosphatidyl cholines" 134 : 459-465, 2003

14 Rashid S, "Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity" 36 : 421-429, 2003

15 Seman LJ, "Lipoprotein(a), homocysteine, and remnantlike particles: emerging risk factors" 14 : 186-191, 1999

16 Lakshman R, "Is alcohol beneficial or harmful for cardioprotection" 5 : 111-120, 2010

17 Millar JS, "Heterogeneity of apolipoprotein B-100-containing lipoproteins: what we have learnt from kinetic studies" 9 : 197-202, 1998

18 Navab M, "HDL as a biomarker, potential therapeutic target, and therapy" 58 : 2711-2717, 2009

19 Jenkins DJ, "Glycemic index of foods: a physiological basis for carbohydrate exchange" 34 : 362-366, 1981

20 National Cholesterol Education Program (NCEP), "Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report" 106 : 3143-3421, 2002

21 Friedewald WT, "Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge" 18 : 499-502, 1972

22 Ratliff JC, "Eggs modulate the inflammatory response to carbohydrate restricted diets in overweight men" 5 : 6-, 2008

23 Wood RJ, "Effects of a carbohydrate-restricted diet on emerging plasma markers for cardiovascular disease" 3 : 19-, 2006

24 Denke MA, "Dietary fat, fatty acids and their effects on lipoproteins" 8 : 466-471, 2006

25 Mutungi G, "Dietary cholesterol from eggs increases HDL cholesterol in overweight men consuming a carbohydrate restricted diet" 138 : 272-276, 2008

26 Volek JS, "Dietary carbohydrate restriction induces a unique metabolic state positively affecting atherogenic dyslipidemia, fatty acid partitioning and metabolic syndrome" 47 : 307-318, 2008

27 Hulthe J, "Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study)" 22 : 1162-1167, 2002

28 Tall AR, "Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins" 263 : 256-273, 2008

29 Al-Sarraj T, "Carbohydrate restriction as a first-line dietary intervention therapy effectively reduces the biomarkers of metabolic syndrome in Emirati adults" 139 : 1667-1676, 2009

30 Wood RJ, "Carbohydrate restriction alters lipoprotein metabolism by modifying VLDL, LDL and HDL subfraction distribution and size in overweight men" 136 : 384-389, 2006

31 Austin MA, "Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk" 82 : 495-506, 1990

32 Gardner CD, "Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women" 276 : 875-881, 1996

33 Yamashita T, "Arterial compliance, blood pressure, plasma leptin, and plasma lipids in women are improved with weight reduction equally with a meat-based diet and a plant-based diet" 47 : 1308-1314, 1998

34 Shachter NS, "Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism" 12 : 297-304, 2001

35 Gianturco SH, "Apolipoprotein B-48 or Its Apolipoprotein B-100 Equivalent Mediates the Binding of Triglyceride-Rich lipoproteins to Their Unique Human Monocyte-Macrophage Receptor" 18 : 968-976, 1998

36 Lee JY, "ATP-binding cassette transporter AI and its role in HDL formation" 16 : 19-25, 2005

37 Fitzgerald ML, "ABC transporters, atherosclerosis and inflammation" 211 : 361-370, 2010